(18 March 2016, Beijing)Universal Medical Financial & Technical Advisory Services Company Limited( “Universal Medical” or the “Company”; stock code:2666) held “the Meeting on Multi-discipline Establishment of CVA(Cerebral Vascular Accident) Base Hospitals and Promotion of Hierarchical Treatment” in Henan province, during which the Company invited leading experts including Prof. Yong Qiang and Prof. Feng Liqun from Beijing Anzhen Hospital, Director Gu Jianqin from Henan People’s Hospital together with Doctor Zhu Liangfu, head of its invasive technology department and Doctor Zhang Lianzhong, head of its medical development department. These doctors had a in-depth discussion on academic subjects like ultrasound hierarchical treatment, vessel recanalization after acute ischemic CVA and hospital management to promote CVA projects focusing on the above subjects as well as general practitioners. Universal Medical will establish a long-term strategic cooperative partnership with Henan People’s Hospital and make its partnered hospital a forefront to implement the three-level treatment system promoted by the central government and therefore push ahead the medical reform.

An Active Reform Booster

Death toll of noninfectious chronic diseases(“NCD”) has accounted for 85% of China’s total mortality, giving rise to 70% of Chinese medical expenditure. The morbidity of cardiovascular and cerebrovascular diseases has been ascending in recent years. According to “Report on China’s CVA Prevention and Treatment, 2015”, CVA has been found the biggest killer to residents’ health and therefore it’s more than important to do the screening, diagnosis and treatment in advance. China initiated CVA Prevention and Treatment Project to solve the problem while Universal Medical, as an important subsidiary under the umbrella of Genertec, a key state-owned enterprise under the direct supervision of the central government, deems it a great social responsibility to promote the medical reform and therefore started CVA projects as early as 6 years ago. The Company’s consistent multi-discipline CVA model has laid a great practical foundation for other fields of disease, also making good contribution to the research of China’s chronic disease treatment.

Eye on Real Needs of Base Hospitals

At present, China is short of systematic organizations and technical standards in NCD prevention and treatment. There is a huge gap among medical institutions in different regions and untight cooperation among various disciplines. Universal Medical has been committed to the establishment of CVA prevention and treatment centers with the aim of enhance China’s capability in cardiovascular and cerebrovascular diseases prevention and treatment. The aforesaid meeting in Henan was a training mode for local CVA diagnosis and treatment and would provide effective assistance for base hospitals like Henan People’s Hospital.

Brainstorm of Leading Experts

The Company realized the real needs of its base hospitals and made great use of its own medical resources platform to invite leading experts like Prof. Yong Qiang and Prof. Feng Liqun from Beijing Anzhen Hospital, Director Gu Jianqin from Henan People’s Hospital together with Doctor Zhu Liangfu, head of its invasive technology department and Doctor Zhang Lianzhong, head of its medical development department. The brains shared academic subjects like ultrasound hierarchical treatment, vessel recanalization after acute ischemic CVA and hospital management to promote CVA projects focusing on the above subjects as well as general practitioners and accelerate to establish the hierarchical treatment system for Henan People’s hospital as a long-range objective.

Experts’ Profile

Prof. Yong Qiang

Head of Comprehensive Ultrasound, Chief Physician and Master Supervisor from Beijing Anzhen Hospital, Capital Medical University;

Standing Deputy Director of Vessel Ultrasound Committee, Ultrasound Physician Chapter, Chinese Medical Doctor’s Association;

Deputy Director of Superficial Organs and Peripheral Vessel Ultrasound Committee, Chinese Medical Ultrasonic Engineering Association;

Director of Cardiovascular Ultrasound Chapter, Chinese Cardiovascular Anesthesia Association;

Leader of researches under national projects and the compiler of cardiovascular ultrasound-related textbooks.

Prof. Feng Liqun

Head of Neurology Department, Chief Physician and Master Supervisor from Beijing Anzhen Hospital, Capital Medical University;

Leader of a national key project on bio-macromolecule and a natural science fund project under Chinese Academy of Sciences;

Published nearly 40 articles on core journals home and abroad including 4 on SCI, 1 translated works as well as 9 compilations.

Gu Jianqin

Director and Deputy Secretary of Party Committee, Henan People’s Hospital;

Former Director and Deputy Secretary of Party Committee, Zhengzhou Fifth People’s Hospital;

Former Deputy Director and Deputy Secretary, Zhengzhou Health Bureau;

Experienced in CVA prevention and treatment.

Zhu Liangfu

Head of Cerebral Vascular Intervention Department B, Chief Physician and Master Supervisor from Henan People’s Hospital;

Deputy Director of Henan Intervention Medical Center;

Deputy Director of National Advanced CVA Center and Teaching & Research Center;

Standing Member of Young and Middle-aged Experts Committee under NHFPC CVA Prevention and Treatment Project;

Visiting scholar of UCLA Stroke Center;

Specialized in cerebrovascular disease prevention and treatment as well as interventional diagnosis.

Zhang Lianzhong, PhD

Deputy Head of Ultrasound Department, Chief Physician from Henan People’s Hospital;

Returnee from Australia available to the special allowance of the State Council;

Director of Chinese Medical Ultrasonic Engineering Association;

Standing Member of Treatment Committee and Family Planning Ultrasound Committee, Chinese Medical Ultrasonic Engineering Association;

Member of Ultrasound Intervention Committee, China Medical Imaging Technology Association;

Deputy Director of Henan Ultrasound Chapter and Zhengzhou Ultrasound Session, Chinese Medical Association;

Outstanding Talent Title of Henan People’s Hospital.